HCI Group, Inc. remains fundamentally strong, with robust Q4 2025 growth and margins despite recent share price weakness. Read more on HCI stock here.
Dupixent growth offsets Eylea declines; pipeline/Libtayo impact post-2026; monitor ROIC & SBC. Click for a REGN update.